检查多药丸在预防心血管疾病中的使用
Andy Wang1, Kassidy Veasaw, Sarah Subhan
1From the Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY.
Cardiology in review
|July 4, 2023
概括
多种药丸,一个单一的药丸结合多种心血管药物,显著减少心血管疾病 (CVD) 的事件,并改善药物坚持. 这种全合一疗法为预防心血管疾病提供了一个有希望的,具有成本效益的策略.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 现有的心血管疾病预防策略在遵守和可访问性方面面临挑战.
- 多药丸提供了一种整合的治疗方法来应对这些挑战.
研究的目的:
- 评估多药丸在减少心血管事件中的有效性.
- 评估多药丸对心血管疾病风险因素的影响.
- 为了确定多药丸的成本效益和对药物坚持的影响.
主要方法:
- 临床试验的审查,调查使用多药剂预防心血管疾病.
- 分析关于心脏病发病率,风险因素降低和治疗遵守情况的数据.
- 多药丸治疗的经济评价.
主要成果:
- 多种药丸的使用表明,心血管事件和风险因素的显著减少.
- 在使用多种药丸的患者中观察到高水平的治疗顺应率.
- 发现多药丸具有成本效益,并改善药物坚持,特别是在基线遵守率较低的人群中.
结论:
- 多种药丸是一种有前途的治疗策略,用于心血管疾病的初级和二级预防.
- 它的全合一性质提高了可访问性,可负担性和坚持性,特别是在资源有限的环境中.
- 多种药丸在管理全球心血管疾病负担方面取得了重大进展.
更多相关视频
相关概念视频
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
Assessment of the Cardiovascular System I: Subjective Data
370
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
370
Coronary Artery Disease V: Interprofessional Care
10
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


